According to EvaluatePharma, Aubagio's sales rose from $1 billion to $1.2 billion in the year 2016-2017.
Since the end of 2014, Aubagio has been using Revenge star Madeleine Stowe to travel across the US for awareness events.
Overview
Aubagio is a pill that treats relapsing forms of MS. Today the company is enjoying a great increase in sales that is as high as 21%.
Below I have provided information on the drug Aubagio that includes a general overview of the drug, key success factors, US sales, and distribution and prescribers.
INTRODUCTION TO AUBAGIO AND PATENTS
Aubagio is a pill that treats relapsing forms of MS. It is a once-daily pill that has proven to quiet MS. Aubagio came into the market in 2012 in a situation that was far from ideal. However, today the company is enjoying a great increase in sales that is as high as 21%. According to EvaluatePharma, their sales rose from $1 billion to $1.2 billion in the year 2016-2017. Christina Rossi, from Sanofi Genzyme, states that Aubagio was able to overcome its challenges by using real-world data and taking an interest, as an investor, in two Phase-III studies, which showed the product's efficacy. The Phase-III studies demonstrated that Aubagio was the only oral therapy that produced an impact on the progression of disabilities. …show more content…
According to the website Drugs, there are three patents related to Aubagio. One of these patents expires in 2026, another in 2030 and another in 2034.
KEY SUCCESS